BRCA1 and cancer: In other cancers and senescence-associated disorders, aberrant activation of pericentromeric chromatin has been linked to BRCA1 mutations (49, 54) and malfunction of various epigenetic modifiers, including histone deacetylase SIRT6 (55) and DNA methyltransferases DNMT1 and DMNT3B (56).